Child development at 6 years after maternal cancer diagnosis and treatment during pregnancyTineke Vandenbroucke, Vít Drochýtek, Magali Verheecke et al.|European Journal of Cancer|2020Cited by 61
CD34 <sup>+</sup> progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg <sup>null</sup> miceJolien M.R. Van der Meer, Harry Dolstra, Paul K.J.D. de Jonge et al.|OncoImmunology|2021Cited by 19
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II StudySusana Banerjee, George Coukos, Eleonora Ghisoni et al.|Clinical Cancer Research|2025Cited by 12
Supplementary Table S1 from Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II StudySusana Banerjee, George Coukos, Eleonora Ghisoni et al.|Unknown|2025Cited by 0
Supplementary Figure S3 from Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II StudySusana Banerjee, George Coukos, Apostolos Sarivalasis et al.|Unknown|2025Cited by 0